Ischemic heart disease is a complex disease process caused by the development of coronary atherosclerosis, with downstream effects on the left ventricular myocardium. It is characterized by a long preclinical phase, abrupt development of myocardial infarction, and more chronic disease states such as stable angina and ischemic cardiomyopathy.
PATHOPHYSIOLOGY OF ISCHEMIC HEART DISEASE
Coronary atherosclerosis is a chronic progressive disease with a long and mostly unrecognized preclinical phase. The first pathological abnormality, the fatty streak, can be observed as early as the second decade of life (1) . Ultimately, these streaks develop into mature atherosclerotic plaques consisting of a central lipid core covered by a fibrous cap.
As the plaque grows, the affected vessel expands in an outward direction, preserving both the luminal diameter and blood flow, in a process known as positive remodeling.
Consequently, even large plaques can be accommodated without producing symptoms and without being identified on invasive angiography or stress testing. Eventually, the plaque begins to grow into the lumen of the vessel, obstructing blood flow and causing myocardial ischemia and symptoms of angina pectoris. Importantly, although the degree of luminal stenosis is closely related to the development of myocardial ischemia, multiple other factors such as entrance effects, friction, and turbulence, also contribute to increased flow resistance across a particular stenosis (2) . Moreover, it is now well established that most myocardial infarctions (MIs)
arise from plaques that are nonobstructive on antecedent angiography, in part related to the much greater prevalence of these lesions (3, 4) . suggested that most of these so-called vulnerable plaques either heal or rupture subclinically rather than cause ACS (7), such features rarely exist in isolation and can serve as a marker of patients with advanced and metabolically active atheroma (7, 8 Both myocardial ischemia and infarction can have a profound effect on the structure and function of the left ventricular myocardium. MI results in tissue necrosis and ultimately irreversible areas of scarring, reducing the ability of the heart to both contract and relax. MI also results in areas of stunned myocardium, regions of hypokinesia that are damaged but not infarcted, with the potential to regain function.
Similarly, severe myocardial ischemia can result in hibernating myocardium, areas with impaired function that can be restored if blood flow is improved.
Ultimately, these insults to cardiac function can lead to congestive cardiac failure and development of ischemic cardiomyopathy.
IMAGING WITH CT AND CMR
The successful application of CT and CMR imaging to the heart was delayed compared with application to static organ systems, principally due to the heart's complex motion during both the cardiac and the respiratory cycles. However, advances in scan- CT and CMR in Ischemic Heart Disease N O V E M B E R 1 5 / 2 2 , 2 0 1 6 : 2 2 0 1 - Both CT and CMR offer detailed and comprehensive imaging of ischemic heart disease. Gold-outlined boxes highlight preferred modalities. CT currently holds the advantage for coronary imaging, whereas CMR offers more detailed assessments of the myocardium. Orange areas on the coronary CTA outline areas of low attenuation Coronary CTA shows a nonobstructive plaque in the LAD artery (A). However, this plaque has high-risk characteristics including positive remodeling with a large plaque volume and areas of low attenuation (<30 HU, orange areas) on cross-sectional imaging (image without color overlay also shown, inset) (B). In this patient the plaque in question went on to rupture and cause an acute ST-segment elevation myocardial infarction with occlusion of the LAD (C). Coronary MRA from a different patient demonstrates proximal coronary artery stenosis, which colocalizes with a high-intensity plaque on noncontrast T1-weighted imaging (yellow arrows) (D, E). D and E adapted with permission from Noguchi et al. (38) . LAD ¼ left anterior descending artery; other abbreviations are as in Central Illustration.
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patients, T1-weighted imaging detected thrombus at the site of the culprit coronary plaque with a sensitivity and specificity of w90% (36 is that these sequences acquire information across the entire volume of the heart and are therefore not limited by sampling error. However, they lack anatomic information, so they must be fused with CMR angiographic scans ( Figure 2) . Although it is a promising approach, large multicenter studies are required before noncontrast T1-weighted coronary imaging can be recommended clinically. 
